Literature DB >> 24368089

Golgin-84-associated Golgi fragmentation triggers tau hyperphosphorylation by activation of cyclin-dependent kinase-5 and extracellular signal-regulated kinase.

Qian Jiang1, Lu Wang2, Yang Guan2, Hui Xu2, Yi Niu2, Li Han2, Yu-Ping Wei2, Li Lin2, Jiang Chu2, Qun Wang2, Ying Yang2, Lei Pei2, Jian-Zhi Wang3, Qing Tian4.   

Abstract

Tau hyperphosphorylation is a critical event in Alzheimer's disease, in which the neuronal Golgi fragmentation occurs earlier than tau hyperphosphorylation. However, the intrinsic link between Golgi impairment and tau pathology is missing. By electron microscopy and western blotting, we observed in the present study that the neuronal Golgi fragmentation was increased age-dependently with a correlated tau hyperphosphorylation in the brains of C57BL/6 mice aged from 4 to 16 months. Simultaneously, golgin-84 and Golgi reassembly stacking protein 65, 2 important Golgi matrix proteins, were decreased in the brains of elder mice. Further studies in HEK293/tau cells showed that Golgi-disturbing agents, brefeldin A and nocodazole induced tau hyperphosphorylation. Knockdown of golgin-84, not Golgi reassembly stacking protein 65, by small interfering RNA was sufficient to induce tau hyperphosphorylation, while over-expressing golgin-84 arrested the brefeldin A-induced Golgi fragmentation and tau hyperphosphorylation. Finally, we demonstrated that cyclin-dependent kinase-5 and extracellular signal-regulated kinase were activated after golgin-84 knockdown, and simultaneous inhibition of these kinases abolished the golgin-84 deficit-induced tau hyperphosphorylation. These data suggest Golgi fragmentation could be an upstream event triggering tau hyperphosphorylation through golgin-84 deficit-induced activation of cyclin-dependent kinase-5 and extracellular signal-regulated kinase.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Golgi fragmentation; Golgin-84; Tau

Mesh:

Substances:

Year:  2013        PMID: 24368089     DOI: 10.1016/j.neurobiolaging.2013.11.022

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  20 in total

Review 1.  Role of the Golgi Apparatus in the Blood-Brain Barrier: Golgi Protection May Be a Targeted Therapy for Neurological Diseases.

Authors:  Shuwen Deng; Hui Liu; Ke Qiu; Hong You; Qiang Lei; Wei Lu
Journal:  Mol Neurobiol       Date:  2017-07-20       Impact factor: 5.590

2.  Fragmentation of the Golgi complex of dopaminergic neurons in human substantia nigra: New cytopathological findings in Parkinson's disease.

Authors:  Mónica Tomás; Emma Martínez-Alonso; Narcisa Martínez-Martínez; Mireia Cara-Esteban; José A Martínez-Menárguez
Journal:  Histol Histopathol       Date:  2020-10-20       Impact factor: 2.303

Review 3.  New insights into the role of the Golgi apparatus in the pathogenesis and therapeutics of human diseases.

Authors:  Wooseon Choi; Shinwon Kang; Jiyoon Kim
Journal:  Arch Pharm Res       Date:  2022-09-30       Impact factor: 6.010

4.  Mutations in the COPI coatomer subunit α-COP induce release of Aβ-42 and amyloid precursor protein intracellular domain and increase tau oligomerization and release.

Authors:  Jacob W Astroski; Leonora K Akporyoe; Elliot J Androphy; Sara K Custer
Journal:  Neurobiol Aging       Date:  2021-01-13       Impact factor: 4.673

5.  Genotype & phenotype in Lowe Syndrome: specific OCRL1 patient mutations differentially impact cellular phenotypes.

Authors:  Swetha Ramadesikan; Lisette Skiba; Jennifer Lee; Kayalvizhi Madhivanan; Daipayan Sarkar; Agustina De La Fuente; Claudia B Hanna; Genki Terashi; Tony Hazbun; Daisuke Kihara; R Claudio Aguilar
Journal:  Hum Mol Genet       Date:  2021-04-26       Impact factor: 6.150

Review 6.  Small GTPases of the Rab and Arf Families: Key Regulators of Intracellular Trafficking in Neurodegeneration.

Authors:  Alazne Arrazola Sastre; Miriam Luque Montoro; Hadriano M Lacerda; Francisco Llavero; José L Zugaza
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

7.  Changes in the Golgi Apparatus of Neocortical and Hippocampal Neurons in the Hibernating Hamster.

Authors:  Alejandro Antón-Fernández; Gonzalo León-Espinosa; Javier DeFelipe; Alberto Muñoz
Journal:  Front Neuroanat       Date:  2015-12-15       Impact factor: 3.856

Review 8.  Golgi fragmentation in Alzheimer's disease.

Authors:  Gunjan Joshi; Michael E Bekier; Yanzhuang Wang
Journal:  Front Neurosci       Date:  2015-09-24       Impact factor: 4.677

9.  Valproate pretreatment protects pancreatic β-cells from palmitate-induced ER stress and apoptosis by inhibiting glycogen synthase kinase-3β.

Authors:  Shan Huang; Minghui Zhu; Wei Wu; Abid Rashid; Yan Liang; Ling Hou; Qin Ning; Xiaoping Luo
Journal:  J Biomed Sci       Date:  2014-05-04       Impact factor: 8.410

10.  Alteration of Golgi Structure by Stress: A Link to Neurodegeneration?

Authors:  Eduardo A Alvarez-Miranda; Markus Sinnl; Hesso Farhan
Journal:  Front Neurosci       Date:  2015-11-12       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.